While our findings suggest that SAFB2 has tumor-suppressive potential in PDAC, its precise role and underlying regulatory mechanisms, particularly in relation to the inhibition of Wnt/β-Catenin signaling and suppression of tumor progression, remain to be fully elucidated. The gene discussed is SAFB2; the disease is neoplasm.